Title: Urinary Oxytocin Levels in Children Receiving Animal-Assisted Therapy
NCT ID: NCT06414876
Last Updated: 2024-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2016-02-02
2017-05-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim: To investigate changes in oxytocin levels in hospitalized children during animal-assisted therapy sessions with a certified hospital dog.
Method: Urine samples were collected from 35 hospitalized children (3-17 years) before and after each participant had a session with the hospital dog. Oxytocin levels were analysed with an acetylcholinesterase (AChE) competitive enzyme-linked immunosorbent assay (ELISA). Creatinine levels were measured to determine the subject's fluid intake and then divided by the hormonal concentration (uOT pg/mg).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxytocin Levels in Typically Developing Boys
NCT02006381
The Influence of Oxytocin on Pair-bonding and Emotion Regulation
NCT02501837
Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome
NCT04283578
Oxytocin Modulation of Startle Reactivity to Social Stimuli and Moral Decision Making
NCT01607970
Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome
NCT02804373
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The children played with the hospital dog and then by themselves.
Hospital dog
The hospital dog always has a well educated dog instructor beside.
The children played by themselves and then with the hospital dog.
Hospital dog
The hospital dog always has a well educated dog instructor beside.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hospital dog
The hospital dog always has a well educated dog instructor beside.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Immunosuppressed
* Large burns
3 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UOLinCRAAT_Uppsala University
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.